Transaction in Own Shares

AI SummaryClose X

RTW Biotech Opportunities bought back 377,705 ordinary shares on 19 November 2026 at $2.42 per share to be held in treasury; following settlement issued share capital is 345,967,440 with 29,505,322 shares (8.53% of issued) in treasury and total voting rights of 316,462,118. The repurchase was executed under shareholder authority permitting repurchases up to 14.99% (valid until the next AGM), the company will not pay a price that would be a premium to net asset value and currently intends to retain repurchased shares in treasury.

Disclaimer*

UK 100

Latest directors dealings